Clinical trial
A Phase I Dose Escalation Trial: Concurrent Intensity-Modulated Radiotherapy (IMRT) and Chemotherapy With Molecular Image-Guided Adaptive Radiation Therapy (IGART) for Advanced Head and Neck Squamous Cell Carcinomas (HNSCC)
NCT01283178 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Dose Escalation Trial: Concurrent Intensity-Modulated Radiotherapy (IMRT) and Chemotherapy With Molecular Image-Guided Adaptive Radiation Therapy (IGART) for Advanced Head and Neck Squamous Cell Carcinomas (HNSCC)
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- July 31, 2011
- Completion date
- September 30, 2016
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
salivary gland squamous cell carcinoma, stage ii salivary gland cancer, stage ii squamous cell carcinoma of the hypopharynx, stage ii squamous cell carcinoma of the lip and oral cavity, stage ii squamous cell carcinoma of the oropharynx, stage ii verrucous carcinoma of the oral cavity, stage iii salivary gland cancer, stage iii squamous cell carcinoma of the hypopharynx, stage iii squamous cell carcinoma of the lip and oral cavity, stage iii squamous cell carcinoma of the oropharynx, stage iii verrucous carcinoma of the oral cavity, stage iv salivary gland cancer, stage iv squamous cell carcinoma of the hypopharynx, stage iv squamous cell carcinoma of the lip and oral cavity, stage iv squamous cell carcinoma of the oropharynx, stage iv verrucous carcinoma of the oral cavity